These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8885716)

  • 21. Genetic background determines phenotypic severity of the Plp rumpshaker mutation.
    Al-Saktawi K; McLaughlin M; Klugmann M; Schneider A; Barrie JA; McCulloch MC; Montague P; Kirkham D; Nave KA; Griffiths IR
    J Neurosci Res; 2003 Apr; 72(1):12-24. PubMed ID: 12645075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protooncogene Ski controls Schwann cell proliferation and myelination.
    Atanasoski S; Notterpek L; Lee HY; Castagner F; Young P; Ehrengruber MU; Meijer D; Sommer L; Stavnezer E; Colmenares C; Suter U
    Neuron; 2004 Aug; 43(4):499-511. PubMed ID: 15312649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations in the mouse myelin basic proteins result in a range of dysmyelinating disorders.
    Jacobs EC
    J Neurol Sci; 2005 Feb; 228(2):195-7. PubMed ID: 15694204
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenotypic clustering in MPZ mutations.
    Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
    Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
    Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
    Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biology and pathobiology of Schwann cells.
    Scherer SS
    Curr Opin Neurol; 1997 Oct; 10(5):386-97. PubMed ID: 9330884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene.
    Edgar JM; McLaughlin M; Barrie JA; McCulloch MC; Garbern J; Griffiths IR
    Acta Neuropathol; 2004 Apr; 107(4):331-5. PubMed ID: 14745569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
    Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
    J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation, purification and expansion of myelination-competent, neonatal mouse Schwann cells.
    Honkanen H; Lahti O; Nissinen M; Myllylä RM; Kangas S; Päiväläinen S; Alanne MH; Peltonen S; Peltonen J; Heape AM
    Eur J Neurosci; 2007 Aug; 26(4):953-64. PubMed ID: 17714189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological mutations affecting myelination in the central nervous system.
    Baumann N; Jacque C; Zalc B; Maurin Y; Lachapelle F; Castaigne P
    Int J Neurol; 1982-1983; 16-17():95-101. PubMed ID: 6765662
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
    Maier M; Berger P; Nave KA; Suter U
    Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination.
    Sahenk Z
    Ann N Y Acad Sci; 1999 Sep; 883():415-26. PubMed ID: 10586265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
    Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
    Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental loss of NT-3 in vivo results in reduced levels of myelin-specific proteins, a reduced extent of myelination and increased apoptosis of Schwann cells.
    Woolley AG; Tait KJ; Hurren BJ; Fisher L; Sheard PW; Duxson MJ
    Glia; 2008 Feb; 56(3):306-17. PubMed ID: 18080292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression in brain during cuprizone-induced demyelination and remyelination.
    Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
    Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An introduction to the molecular basis of inherited myelin diseases.
    Matthieu JM
    J Inherit Metab Dis; 1993; 16(4):724-32. PubMed ID: 7692129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trembler as a mouse model of CMT1A?
    Garbay B; Salles J; Knoll A; Boiron-Sargueil F; Heape AM; Bonnet J; Cassagne C
    Ann N Y Acad Sci; 1999 Sep; 883():262-72. PubMed ID: 10586251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts of PLP and its role in the nervous system.
    Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
    Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.